Covalon Technologies (CVE:COV) Trading Down 16.7% - Time to Sell?

Key Points

• Covalon Technologies Ltd. experienced a significant stock drop of 16.7%, with shares trading down to C$2.40 from a previous close of C$2.88.
• The company has a high debt-to-equity ratio of 3.28 and strong liquidity measures, indicated by a current ratio of 7.27 and a quick ratio of 6.45.
• Covalon focuses on developing medical products for infection management and wound care, serving markets in North America, the Middle East, Asia, and Latin America.

Covalon Technologies Ltd. (CVE:COV - )'s share price dropped 16.7% on Friday . The stock traded as low as C$2.36 and last traded at C$2.40. Approximately 181,028 shares traded hands during trading, an increase of 555% from the average daily volume of 27,638 shares. The stock had previously closed at C$2.88.

Covalon Technologies Stock Performance

The company has a debt-to-equity ratio of 3.28, a current ratio of 7.27 and a quick ratio of 6.45. The stock has a 50-day moving average price of C$2.52 and a 200-day moving average price of C$2.51. The firm has a market capitalization of C$65.76 million, a PE ratio of 27.55 and a beta of 0.64.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.